Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T-cell pathway in patients with diffuse large B-cell lymphoma

Hematol Oncol. 2023 Dec;41(5):947-950. doi: 10.1002/hon.3211. Epub 2023 Jul 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Neoplasm Recurrence, Local
  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen*
  • T-Lymphocytes
  • Transplantation, Homologous

Substances

  • Receptors, Chimeric Antigen
  • pixantrone
  • Receptors, Antigen, T-Cell